General Information of the Compound
| Compound ID |
CP0474397
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [hydroxy-[hydroxy-[[(2R,3S,4S,5S)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]phosphoryl]oxyphosphoryl] hydrogen phosphate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H26N2O23P4
|
||||||||||||||||||
| Molecular Weight |
726.26
|
||||||||||||||||||
| Canonical SMILES |
O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2OC(O)[C@@H](O)[C@@H](O)[C@@H]2O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H26N2O23P4/c18-7-1-2-17(15(25)16-7)13-11(22)9(20)5(36-13)3-34-41(26,27)38-43(30,31)40-44(32,33)39-42(28,29)35-4-6-8(19)10(21)12(23)14(24)37-6/h1-2,5-6,8-14,19-24H,3-4H2,(H,26,27)(H,28,29)(H,30,31)(H,32,33)(H,16,18,25)/t5-,6-,8-,9-,10+,11-,12+,13-,14?/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
RZHCKCCBWWACOW-BHARQNLVSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04714, P2Y purinoceptor 2
Protein ID: PT05219, P2Y purinoceptor 4
Protein ID: PT02796, P2Y purinoceptor 6